Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Title Intervention NCT IDsort descending Sponsor Status
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin, Placebo Administration NCT02743364 National Cancer Institute (NCI) Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid NCT02772003 National Cancer Institute (NCI) Active, not recruiting
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim NCT02780401 University of Washington Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment NCT02782949 National Cancer Institute (NCI) Active, not recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Retinoid 9cUAB30, Therapeutic Conventional Surgery NCT02876640 National Cancer Institute (NCI) Recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib Hydrochloride, Erlotinib NCT02961374 National Cancer Institute (NCI) Active, not recruiting
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration NCT02965703 National Cancer Institute (NCI) Active, not recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Placebo Administration, Questionnaire Administration, Simvastatin NCT02968810 National Cancer Institute (NCI) Recruiting
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate NCT02993159 Northwestern University Recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Active, not recruiting

Pages